Osteosarcoma Vaccine Study
Now Enrolling PatientsStudy Overview
The primary objective of this study is to evaluate the efficacy of a novel vaccine as compared to standard of care (Carboplatin) following amputation as treatment for canine appendicular osteosarcoma.
Eligibility Criteria
- Dog is ≥ 1 year of age
- Dog is ≥ 44lbs
- Dog is in good general health with the exception of appendicular osteosarcoma
- Dog had cytologic and/or histologic confirmation of appendicular osteosarcoma
Study Timeline
- 6-8 Months
- 10-12 clinic visits per patient
Interested in this study?
Reach out to a participating hospital to learn more!
Ethos Hospitals
Colorado Animal Specialty & Emergency (CASE): Boulder, CO
First Coast Veterinary Specialists & Emergency (FCVS): Jacksonville Beach, FL
Metropolitan Veterinary Hospital: Cleveland, OH
Metropolitan Veterinary Hospital: Akron, OH
Massachusetts Veterinary Referral Hospital (MVRH): Woburn, MA
Mission Veterinary Emergency & Specialty (MVES): Mission, KS
Peak Veterinary Referral Center: Williston, VT
Southeast Veterinary Oncology & Internal Medicine: Orange Park, FL
Veterinary Specialty Hospital – North County: San Marcos, CA